Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA ZYDUS LIFESCIENCES CIPLA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 32.2 34.2 94.1% View Chart
P/BV x 5.2 5.8 89.5% View Chart
Dividend Yield % 0.6 0.6 95.3%  

Financials

 CIPLA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    CIPLA
Mar-23
ZYDUS LIFESCIENCES
Mar-23
CIPLA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,185495 239.5%   
Low Rs852319 266.8%   
Sales per share (Unadj.) Rs281.9170.3 165.5%  
Earnings per share (Unadj.) Rs35.119.8 177.6%  
Cash flow per share (Unadj.) Rs49.726.9 184.5%  
Dividends per share (Unadj.) Rs8.506.00 141.7%  
Avg Dividend yield %0.81.5 56.6%  
Book value per share (Unadj.) Rs289.2173.0 167.1%  
Shares outstanding (eoy) m807.151,012.20 79.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.62.4 151.1%   
Avg P/E ratio x29.020.6 140.8%  
P/CF ratio (eoy) x20.515.1 135.6%  
Price / Book Value ratio x3.52.4 149.7%  
Dividend payout %24.230.3 79.8%   
Avg Mkt Cap Rs m822,164412,144 199.5%   
No. of employees `000NANA-   
Total wages/salary Rs m38,30124,564 155.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m227,531172,374 132.0%  
Other income Rs m5,1214,746 107.9%   
Total revenues Rs m232,653177,120 131.4%   
Gross profit Rs m48,07929,677 162.0%  
Depreciation Rs m11,7217,227 162.2%   
Interest Rs m1,0951,299 84.3%   
Profit before tax Rs m40,38425,897 155.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,0295,878 204.6%   
Profit after tax Rs m28,35520,019 141.6%  
Gross profit margin %21.117.2 122.7%  
Effective tax rate %29.822.7 131.2%   
Net profit margin %12.511.6 107.3%  
BALANCE SHEET DATA
Current assets Rs m168,051100,082 167.9%   
Current liabilities Rs m50,33355,267 91.1%   
Net working cap to sales %51.726.0 199.0%  
Current ratio x3.31.8 184.4%  
Inventory Days Days7350 145.7%  
Debtors Days Days794 7.0%  
Net fixed assets Rs m117,318144,776 81.0%   
Share capital Rs m1,6141,012 159.5%   
"Free" reserves Rs m231,845174,146 133.1%   
Net worth Rs m233,460175,158 133.3%   
Long term debt Rs m00-   
Total assets Rs m290,067244,940 118.4%  
Interest coverage x37.920.9 180.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.7 111.5%   
Return on assets %10.28.7 116.7%  
Return on equity %12.111.4 106.3%  
Return on capital %17.815.5 114.4%  
Exports to sales %22.639.2 57.8%   
Imports to sales %8.911.9 74.5%   
Exports (fob) Rs m51,51667,577 76.2%   
Imports (cif) Rs m20,20220,544 98.3%   
Fx inflow Rs m64,28267,577 95.1%   
Fx outflow Rs m20,20220,544 98.3%   
Net fx Rs m44,08047,033 93.7%   
CASH FLOW
From Operations Rs m32,37726,888 120.4%  
From Investments Rs m-23,88511,712 -203.9%  
From Financial Activity Rs m-9,583-44,004 21.8%  
Net Cashflow Rs m-968-5,338 18.1%  

Share Holding

Indian Promoters % 13.4 75.0 17.9%  
Foreign collaborators % 20.0 0.0 -  
Indian inst/Mut Fund % 50.0 18.0 277.3%  
FIIs % 25.7 5.0 515.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.5 25.0 265.9%  
Shareholders   425,731 306,495 138.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    MANKIND PHARMA    SUPRIYA LIFESCIENCE     


More on Cipla vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Cadila Healthcare Share Price Performance

Period Cipla Cadila Healthcare S&P BSE HEALTHCARE
1-Day 1.94% 0.57% 1.18%
1-Month 1.25% 7.77% -0.75%
1-Year 68.02% 107.52% 61.82%
3-Year CAGR 22.53% 32.30% 18.16%
5-Year CAGR 23.24% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.5% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of Cipla, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.